Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.

Interspecies scaling is a useful tool for the prediction of pharmacokinetic parameters from animals to humans, and it is often used for estimating a first-time in human dose. However, it is important to appreciate the mathematical underpinnings of this scaling procedure when using it to predict pharmacokinetic parameter values across animal species. When cautiously applied, allometry can be a tool for estimating clearance in veterinary species for the purpose of dosage selection. It is particularly valuable during the selection of dosages in large zoo animal species, such as elephants, large cats and camels, for which pharmacokinetic data are scant. In Part I, allometric predictions of clearance in large animal species were found to pose substantially greater risks of inaccuracies when compared with that observed for humans. In this report, we examine the factors influencing the accuracy of our clearance estimates from the perspective of the relationship between prediction error and such variables as the distribution of body weight values used in the regression analysis, the influence of a particular observation on the clearance estimate, and the 'goodness of fit' (R(2)) of the regression line. Ultimately, these considerations are used to generate recommendations regarding the data to be included in the allometric prediction of clearance in large animal species.

[1]  R. P. Hunter,et al.  Zoological pharmacology: current status, issues, and potential. , 2002, Advanced drug delivery reviews.

[2]  M. Papich,et al.  Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species. , 2004, Journal of veterinary pharmacology and therapeutics.

[3]  R. P. Hunter,et al.  Drug delivery to captive Asian elephants - treating Goliath. , 2004, Current drug delivery.

[4]  Harold Boxenbaum,et al.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics , 1982, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  C. Solans,et al.  Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. , 1999, American journal of veterinary research.

[6]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[7]  I Mahmood,et al.  Interspecies allometric scaling. Part I: prediction of clearance in large animals. , 2006, Journal of veterinary pharmacology and therapeutics.

[8]  William S. Spector Handbook of Biological Data , 1956 .

[9]  A. Craigmill,et al.  Interspecies considerations in the evaluation of human food safety for veterinary drugs , 2002, AAPS PharmSci.

[10]  H Boxenbaum,et al.  First‐Time‐in‐Human Dose Selection: Allometric Thoughts and Perspectives , 1995, Journal of clinical pharmacology.

[11]  J. Balian,et al.  Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  J. Mordenti,et al.  Interspecies Scaling of Clearance and Volume of Distribution Data for Five Therapeutic Proteins , 1991, Pharmaceutical Research.

[13]  Norman R. Draper,et al.  Applied regression analysis (2. ed.) , 1981, Wiley series in probability and mathematical statistics.

[14]  W. Hayton,et al.  Allometric scaling of xenobiotic clearance: Uncertainty versus universality , 2008, AAPS PharmSci.

[15]  J. Mordenti,et al.  Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.